"Global Strategic Business Process Solutions"

By: Pacific Biomarkers

Biomarkers for the prediction of acute kidney injury: A review on current status and future challenges Biomarker of acute kidney injury (AKI) is strongly associated with increased morbidity and mortality in critically ill patients. The approach to analyzing AKI biomarkers has been to provide pharmaceutical and biotech companies with services for testing robust novel biomarkers that have undergone thorough analytical validation and clinical qualification with the expectation to diagnose early organ injury. Read this insightful whitepaper on ''Biomarkers for early detection of acute kidney injury'' to know more on: How to target biomarkers that can detect acute kidney injury (AKI) and what the potential of an AKI biomarker program is. What are the issues surrounding the best methods of collecting and storing urine used for detection of AKI in human subjects? Acute kidney injury biomarkers performance assesment 

By: Software AG

Digital business transformation is based on an IT architecture transformation with a roadmap for digital capability implementation. Based on the software platforms, digital companies create enhanced or totally new business models which offer completely new digital customer experiences. Established companies are building up software know-how and are acquiring software companies to accelerate their digital transformation by injecting software innovation capabilities into their core business areas. This whitepaper helps to understand what makes today’s digital challengers attractive to customers and consumers, as it highlights their core competencies and differentiators based on their digital software-based technology. Key takeaways from this whitepaper: Digital challengers separate companies from their customers Implementing digital capabilities for digital use cases Digital companies have a micro services-oriented, scalable IT architecture